Common Contracts
2 similar null contracts by Regeneron Pharmaceuticals Inc
Date: November 18, 2014Regeneron Pharmaceuticals Inc • February 12th, 2015 • Pharmaceutical preparations • New York
Credit Suisse Capital LLC (“CS”) and Regeneron Pharmaceuticals, Inc. (“Issuer”) are parties to a warrant transaction pursuant to a November 13, 2013 assignment by Credit Suisse International, an affiliate of Dealer, to CS of such warrant transaction. The warrant transaction is evidenced by the Master Terms and Conditions for Base Warrants Issued by Regeneron Pharmaceuticals, Inc. dated as of October 18, 2011, supplemented by the written confirmation dated as of October 18, 2011 (the “Confirmation”) and amended by the Amendment dated as of May 14, 2014. Terms used herein but are not otherwise defined shall have meanings assigned to them in the Warrant Confirmation.
Date: November 24, 2014Regeneron Pharmaceuticals Inc • February 12th, 2015 • Pharmaceutical preparations • New York
Credit Suisse Capital LLC (“CS”) and Regeneron Pharmaceuticals, Inc. (“Issuer”) are parties to a warrant transaction pursuant to a November 13, 2013 assignment by Credit Suisse International, an affiliate of Dealer, to CS of such warrant transaction. The warrant transaction is evidenced by the Master Terms and Conditions for Base Warrants Issued by Regeneron Pharmaceuticals, Inc. dated as of October 18, 2011, supplemented by the written confirmation dated as of October 18, 2011 (the “Confirmation”) and amended by the Amendments dated as of May 14, 2014 and dated as of November 19, 2014. Terms used herein but are not otherwise defined shall have meanings assigned to them in the Warrant Confirmation.
